2018
DOI: 10.1097/mat.0000000000000669
|View full text |Cite
|
Sign up to set email alerts
|

Design and Development of a Miniaturized Percutaneously Deployable Wireless Left Ventricular Assist Device: Early Prototypes and Feasibility Testing

Abstract: The current left ventricular assist devices (LVADs) are limited by a highly invasive implantation procedure in a severely unstable group of advanced heart failure patients. Additionally, the current transcutaneous power drive line acts as a nidus for infection resulting in significant morbidity and mortality. In an effort to decrease this invasiveness and eliminate drive line complications, we have conceived a wireless miniaturized percutaneous LVAD, capable of being delivered endovascularly with a tether-free… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 15 publications
0
10
0
Order By: Relevance
“…Over the years there have been significant discussions in the VAD community towards achieving a goal of reduced adverse events by eliminating drivelines for power delivery. We sincerely hope that the current investigation will be able to swing the pendulum in favor of eliminating driveline for the future designs of pumps 17,18 .…”
Section: Discussionmentioning
confidence: 98%
“…Over the years there have been significant discussions in the VAD community towards achieving a goal of reduced adverse events by eliminating drivelines for power delivery. We sincerely hope that the current investigation will be able to swing the pendulum in favor of eliminating driveline for the future designs of pumps 17,18 .…”
Section: Discussionmentioning
confidence: 98%
“…The current LVADs do relieve symptoms and save lives in advanced heart failure patients; yet, further innovation, like transcutaneous energy transfer systems ( 9 ) or the production of miniaturized percutaneously deployable wireless LVADs ( 10 ), are ongoing and may be necessary to justify utilization of LVADs in earlier stages of heart failure or for more widespread acceptance, especially for destination therapy, in advanced HF. Possible disturbance by external electrical sources like ESD of such devices must be proactively considered.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the overall progress, the implementation of a wireless-based solution for power transfer in LVADs is far from becoming part of the clinical routine. In this direction, new wireless solutions against tissue overheating and fibrotic responses will be essential to avoid power outage and tissue damage with life threatening consequences (Letzen et al 2018 ).…”
Section: Alternative Solutions For High-power Transfermentioning
confidence: 99%